lonza.com — September 2026 traffic, keywords & AI visibility

Search engines send lonza.com an estimated 37,400 visits a month. 99% of it is organic, so it leans very little on paid search. Paid search contributes only about 282 visits a month. Spread across 3,344 ranking keywords, that averages roughly 11 organic visits per keyword.

lonza.com scores 77 out of 100 on our AI visibility scale, grade B. It takes full marks for LLMS.txt. The biggest gap is Crawlability, at 0 of 10 points (robots ✗ · sitemap ✗), worth 10 points if closed. It also loses points on Company profile (19/25), Structured data (0/5) and SEO health (18/20).

The llms.txt on lonza.com runs to 150 lines (8,781 characters) across 12 sections, last generated in June 2026. It introduces the site as "Lonza Group". It tells AI engines the business works in Healthcare, Life Sciences & Wellness; Manufacturing, Industrials & Materials; and Research, Science & Deep Tech. It describes 4 products, including Biologics Manufacturing, Cell and Gene Therapy Services and Small Molecule APIs. Services it lists include Process Development, Regulatory Support and Scale-up Services. Technologies it mentions include Bioprocessing equipment, Cell culture systems and Purification technologies. The keywords it claims start with "biomanufacturing", "cell therapy", "gene therapy" and "contract manufacturing". It gives the company type as Public.

# Lonza Group

## About
Lonza Group has built its reputation over more than a century as a reliable Swiss company focused on chemicals and biotechnology. They work closely with pharmaceutical and biotech firms to develop and manufacture medicines that reach patients worldwide. Their expertise covers everything from small molecules to advanced cell and gene therapies. Clients turn to them when they need scalable production without building their own facilities. The company operates multiple sites across Europe, North America and Asia to support global supply chains. Lonza invests heavily in new technologies that speed up development timelines for complex therapies. Their contract manufacturing services help smaller biotechs move from lab to commercial scale. Nutrition and personal care ingredients also form part of their portfolio for consumer health brands. Leadership emphasizes quality systems that meet strict regulatory standards in every market they serve. Partnerships with academic institutions keep them at the forefront of emerging science. The firm maintains a public listing on the Swiss exchange which provides transparency on financial performance. Recent expansions include new capacity for antibody-drug conjugates and viral vector production. Employees across functions contribute to projects that directly impact patient outcomes. Sustainability initiatives focus on redu

Google lists lonza.com for about 3,344 keywords, which together bring an estimated 37,100 organic visits a month.

The latest technical audit of lonza.com scored 72 out of 100 overall. Performance is its weakest area at 26, while accessibility scores highest at 97. The audit makes 12 recommendations in all, and 4 of the 4 listed first are rated high priority or critical.

Lonza Group's company profile names thermofisher.com, merckgroup.com, catalent.com and samsungbiologics.com as competitors. Its own llms.txt adds wuxibiologics.com and boehringer-ingelheim.com. Outside its market, the domains ranked closest to it in our worldwide ranking are animeapp.org, itspl.net, houzeo.com and supersocial.com.br.

thermofisher.com

merckgroup.com

catalent.com

samsungbiologics.com

wuxibiologics.com

boehringer-ingelheim.com